Immunogenicity of a subviral herpes simplex type 1 preparation: reduction of recurrent disease in mice.
Immunization of mice with a relatively small dose of subviral herpes simplex type 1 vaccine used prior to homotypic virus infection reduced the frequency of recurrent disease. However, the same vaccine dose administered after virus infection did not result in significant reduction of recurrences.